---

---

entities : Sanofi    symbols : NVAX   

save search

---

Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -15.03% | O: -0.58% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -43.76% | O: 20.4% H: 26.64% C: 6.13%
covid vaccine positive influenza topline results show

---

Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published: 2023-02-08 (Crawled : 16:00) - prnewswire.com
PFE | News 4 | $26.26 -0.23% 15M |

Health Technology

| -39.62% | O: -0.09% H: 1.26% C: 0.99%
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -8.41% | O: -0.06% H: 0.77% C: 0.19%
EBS | News | $2.145 -6.33% 560K |

Health Technology

| -83.76% | O: -0.78% H: 0.79% C: -5.29%
SNGX | $0.399 -0.25% 330K |

Health Technology

| -94.08% | O: -0.07% H: 4.9% C: 2.27%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| 1.66% | O: 3.05% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -61.52% | O: 0.0% H: 1.74% C: -4.13%
INO | $10.165 -1.98% 150K |

Health Technology

| 457.53% | O: -1.61% H: 2.73% C: -8.47%
BNTX | News | $88.15 -0.38% 170K |

Health Technology

| -37.73% | O: -1.35% H: 1.53% C: 0.68%
research global report vaccine market

---

Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight
Published: 2022-08-31 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| 18.32% | O: 0.75% H: 1.98% C: 1.98%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| 14.25% | O: 1.1% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -88.1% | O: 1.39% H: 1.34% C: -7.48%
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| -20.63% | O: 0.75% H: 2.14% C: -3.42%
CDTX | News | $11.94 16.49% 53K |

Health Technology

| -26.69% | O: 1.15% H: 0.0% C: -3.37%
companies influenza

---

BioSpace Movers & Shakers, April 1
Published: 2022-04-01 (Crawled : 15:00) - biospace.com/
RCOR | $3.2 0.0% |

| -24.53% | O: 0.0% H: 3.19% C: -4.01%
WMT | News | $59.85 1.29% 8.1M |

Retail Trade

| -60.32% | O: 0.5% H: 1.08% C: 0.9%
NVS | News | $98.31 1.06% 1.6M |

Health Technology

| 12.66% | O: -0.64% H: 0.6% C: 0.57%
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -16.64% | O: -1.39% H: 0.0% C: 0.0%
BMY | $48.875 -0.24% 11M |

Health Technology

| -32.92% | O: 0.22% H: 1.01% C: 0.86%
ABT | News | $106.74 -0.79% 3.3M |

Health Technology

| -9.1% | O: 0.41% H: 0.11% C: -0.22%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -9.01% | O: -0.31% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -94.31% | O: -0.48% H: 4.07% C: 1.39%
NKTX | $7.14 -5.56% 470K |

Health Technology

| -33.57% | O: -1.23% H: 4.98% C: 1.78%
ALEC | $5.28 -1.12% 140K |

Health Technology

| -62.53% | O: -0.21% H: 2.39% C: -1.05%

---

New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -5.09% | O: 2.52% H: 1.67% C: 1.67%
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -11.94% | O: -0.85% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -7.76% | O: -0.12% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -94.7% | O: -1.99% H: 2.84% C: 0.35%
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| -24.28% | O: -2.09% H: 0.95% C: 0.01%
covid-19 research covid vaccine

---

Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published: 2022-02-02 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -11.99% | O: 1.26% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -9.71% | O: -0.06% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -95.51% | O: -4.8% H: 4.69% C: -0.33%
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| -37.03% | O: -3.66% H: 3.05% C: -0.68%
covid-19 covid report vaccine

---

Icosavax Provides Corporate Update and Anticipated Milestones for 2022
Published: 2022-01-07 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 480 |

Health Technology

| -6.1% | O: 1.86% H: 0.0% C: 0.0%
ICVX | $15.31 -0.65% 9.3M |

| -20.82% | O: 0.1% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -6.31% | O: -0.1% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -96.62% | O: -1.88% H: 0.0% C: 0.0%
milestone

---

As Omicron Strain Fuels Fresh Waves of Infections Across the Globe, Mutating Coronavirus is the New Pandemic Challenge in 2022
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -12.05% | O: 0.51% H: 0.0% C: 0.0%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -7.14% | O: -2.03% H: 0.0% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -97.07% | O: -2.03% H: 1.27% C: -1.11%
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| -54.1% | O: -1.15% H: 0.0% C: 0.0%
infection infections

---

Worldwide Vaccine Industry to 2027 - Key Drivers, Restraints and Opportunities
Published: 2021-10-13 (Crawled : 19:00) - prnewswire.com
ALPMY | News | $9.49 480K |

Manufacturing

| -44.57% | O: 1.46% H: 0.0% C: -0.4%
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -5.99% | O: 0.32% H: 0.9% C: 0.25%
GSK | News | $40.835 -0.98% 1.1M |

Health Technology

| 6.29% | O: 0.28% H: 0.06% C: -0.49%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -2.41% | O: 1.2% H: 0.08% C: -0.43%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -97.48% | O: 2.18% H: 2.72% C: -0.16%
vaccine

---

Approximately 53% of Global Population to be Fully Vaccinated by the End of 2021
Published: 2021-09-02 (Crawled : 16:00) - prnewswire.com
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -13.86% | O: 0.35% H: 0.49% C: 0.34%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -10.41% | O: 0.13% H: 0.28% C: 0.0%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -98.34% | O: 0.15% H: 3.58% C: 2.59%
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| -72.33% | O: 0.82% H: 2.46% C: 1.15%
vaccine

---

Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance
Published: 2021-08-16 (Crawled : 13:00) - biospace.com/
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -8.67% | O: 0.17% H: 0.62% C: 0.48%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -98.35% | O: -2.28% H: 0.3% C: -7.76%
biopharma

---

BioSpace Movers & Shakers, July 2
Published: 2021-07-02 (Crawled : 12:00) - biospace.com/
PEN F | $205.38 -0.16% 200K |

Health Technology

| -25.55% | O: 0.34% H: 0.0% C: -1.34%
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -9.82% | O: 0.04% H: 1.98% C: 1.78%
BAX | $40.825 -0.48% 1M |

Health Technology

| -49.65% | O: 0.0% H: 0.43% C: 0.36%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -10.46% | O: -0.91% H: 0.0% C: 0.0%
RLMD | $3.775 -3.45% 100K |

Health Technology

| -88.35% | O: -0.27% H: 0.0% C: -2.6%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -98.06% | O: -0.49% H: 0.0% C: 0.0%
LEGN | News | $45.57 -3.96% 630K |

Health Technology

| 13.57% | O: -2.73% H: 1.85% C: 0.91%
BIIB | $199.93 3.49% 2.2M |

Health Technology

| -44.63% | O: 0.18% H: 0.15% C: -0.23%
space spac

---

North America Preventive Vaccines Market: COVID-19 Impact and Growth Opportunity 2021-2026
Published: 2021-06-11 (Crawled : 20:00) - prnewswire.com
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.05 0.28% 4.4M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.835 -0.98% 1.1M |

Health Technology

| Email alert Add to watchlist
covid vaccine growth covid-19

---

European Vaccines Market 2020-2026 by Type, Disease, Administration, Patient, and Country
Published: 2021-06-10 (Crawled : 19:00) - prnewswire.com
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -10.43% | O: -0.01% H: 0.01% C: -1.26%
GSK | News | $40.835 -0.98% 1.1M |

Health Technology

| 2.51% | O: 0.05% H: 0.12% C: -0.25%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -12.5% | O: 0.13% H: 0.11% C: -0.09%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -97.96% | O: -0.21% H: 3.31% C: 2.53%
AZN | News | $71.05 0.28% 4.4M |

Health Technology

| 20.41% | O: 0.49% H: 0.03% C: -0.61%
disease europe vaccine

---

Global Preventive Vaccines Market by Type, Disease, Administration, Patient, and Region 2020-2026
Published: 2021-06-09 (Crawled : 22:00) - prnewswire.com
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -9.62% | O: 0.25% H: 0.95% C: 0.65%
GSK | News | $40.835 -0.98% 1.1M |

Health Technology

| 4.27% | O: 0.76% H: 0.98% C: 0.95%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -10.84% | O: 1.21% H: 1.07% C: 0.67%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -98.0% | O: -1.89% H: 3.4% C: -0.36%
AZN | News | $71.05 0.28% 4.4M |

Health Technology

| 23.0% | O: 0.94% H: 1.27% C: 1.2%
disease vaccine

---

Global Coronavirus (COVID-19) Vaccines Markets, 2019-2020 & 2027: Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed, RNA, DNA, Genetics
Published: 2021-06-04 (Crawled : 00:20) - prnewswire.com
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| Email alert Add to watchlist
ARCT 4 | $26.715 -4.35% 130K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| Email alert Add to watchlist
BNTX | News | $88.15 -0.38% 170K |

Health Technology

| Email alert Add to watchlist
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.05 0.28% 4.4M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| Email alert Add to watchlist
covid genetic vaccine repurposed

---

As India Burns Amid a Lethal 2nd Wave, It's Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?
Published: 2021-05-20 (Crawled : 14:15) - prnewswire.com
JNJ | News | $148.66 -0.6% 5.2M |

Health Technology

| -12.01% | O: -0.08% H: 0.97% C: 0.66%
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -10.96% | O: 1.32% H: 1.12% C: 0.92%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -97.05% | O: 1.39% H: 2.66% C: 1.58%
MRNA | News S | $108.52 0.58% 2.6M |

Health Technology

| -31.71% | O: 1.22% H: 4.31% C: 3.78%
india vaccine

---

Novavax Announces Leadership Updates
Published: 2021-04-13 (Crawled : 22:00) - prnewswire.com
SNY | News | $46.765 -1.94% 1.2M |

Health Technology

| -6.18% | O: 0.56% H: 0.18% C: -0.4%
NVAX | $4.12 -1.67% 1.6M |

Health Technology

| -97.85% | O: 1.46% H: 7.11% C: 1.94%

---

Gainers vs Losers

58%

42%

Top 10 Gainers

CSSE 4 | $0.3831 151.54% 190M |

Consumer Services

CZOO | $11.04 121.24% 11M |

LICN | $0.9107 62.63% 14M |

BOF | $1.87 59.83% 100M |

AMST | $3.18 59.0% 67M |

Technology Services

SKIL 4 | $8.72 52.72% 410K |

Information

MTC | $3.31 47.77% 7.7M |

Technology Services

MULN | News | $3.915 43.41% 12M |

Information

WIMI | $1.04 43.37% 17M |

Technology Services

RILY | $29.755 36.99% 12M |

Finance

---

Your saved searches

---